Trial Profile
Multicentre, Open Study for the Setting up of Population Pharmacokinetic Models and Bayesian Estimators for Individual Dose Adjustment of Immunosuppressive Drugs (Cyclosporine, Tacrolimus, Mycophenolate Mofetil, Everolimus) During the First Year Post-grafting in Adult Heart Transplant Recipients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Dec 2015
Price :
$35
*
At a glance
- Drugs Ciclosporin (Primary) ; Everolimus (Primary) ; Mycophenolate mofetil (Primary) ; Tacrolimus (Primary)
- Indications Heart transplant rejection
- Focus Pharmacogenomic; Pharmacokinetics
- Acronyms PIGREC
- 30 Dec 2008 New trial record.